Loading...
OTCM
LTUS
Market cap264kUSD
Aug 01, Last price  
0.01USD
1D
-3.06%
1Q
79.25%
Jan 2017
331.82%
IPO
-68.33%
Name

Lotus Pharmaceuticals Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
118.59%
Rev. gr., 5y
%
Revenues
0k
134,34836,207,68956,873,11573,803,02957,824,64572,696,61800000
Net income
-19k
L-10.88%
-154,3244,100,73711,217,12812,790,64816,432,29414,424,943-21,829-6,283-30,413-21,108-18,812
CFO
-19k
L-19.67%
-86,9324,778,264-850,45537,394,08431,362,46626,775,776-21,829-6,283-30,413-23,818-19,132

Profile

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.
URL
http://www.lotuspharma.com
IPO date
May 15, 2012
Employees
233
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
(168)
(228)
Tax Rate
NOPAT
168
228
Net income
(19)
-10.88%
(21)
-30.60%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
117
97
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
115
96
Cash flow
Cash from operating activities
(19)
(24)
CAPEX
Cash from investing activities
Cash from financing activities
20
17
FCF
168
225
Balance
Cash
2
1
Long term investments
Excess cash
2
1
Stockholders' equity
(30,099)
(32,774)
Invested Capital
30,105
32,779
ROIC
0.53%
0.73%
ROCE
EV
Common stock shares outstanding
2,694,516
2,694,516
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT